0001104659-21-094094.txt : 20210720
0001104659-21-094094.hdr.sgml : 20210720
20210720193413
ACCESSION NUMBER: 0001104659-21-094094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210719
FILED AS OF DATE: 20210720
DATE AS OF CHANGE: 20210720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Islam Saqib
CENTRAL INDEX KEY: 0001575408
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 211102331
MAIL ADDRESS:
STREET 1: ALEXION PHARMACEUTICALS
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm2122747-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-19
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001575408
Islam Saqib
C/O SPRINGWORKS THERAPEUTICS,
INC., 100 WASHINGTON BLVD.
STAMFORD
CT
06902
1
1
0
0
Chief Executive Officer
Common Stock
2021-07-19
4
S
0
43928
76.0890
D
840124
D
Common Stock
2021-07-20
4
S
0
18572
77.6842
D
821552
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.05 to $77.38, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.90 to $79.23, inclusive.
/s/ Francis I. Perier, Jr as Attorney-in-Fact
2021-07-20